Onychomycosis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032


 Onychomycosis is a fungal infection of the toenails or fingernails that can involve any component of the nail unit, including the matrix, bed, and plate. It is a common disorder that may be a reservoir for infection resulting in significant medical problems. Moreover, onychomycosis can substantially influence one’s quality of life. It affects approximately 2% to 26% of different populations worldwide. It represents 20% to 50% of onychopathies and about 30% of cutaneous fungal infections. The chronic, long-lasting disease may result in nail dystrophy and lead to pain, absence from work, and decreased quality of life, as the dermatophyte can contaminate communal bathing facilities and spread to others. The primary aim of onychomycosis treatment is to cure the infection and prevent relapse. Both topical and oral agents are available to treat fungal nail infections. Generally, systemic therapy for onychomycosis is more successful than topical treatment, likely due to poor penetration of topical medications into the nail plate.

·       The prevalence of Onychomycosis ranges between 15 to 20% population in the USA aged 40 and above.

Thelansis’s “Onychomycosis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Onychomycosis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Onychomycosis across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Onychomycosis Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Onychomycosis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Comments

Post a Comment

Popular posts from this blog

Nephroblastoma – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
 Wilms' Tumor or Nephroblastoma is a rare malignant renal tumor that typically affects children, characterized by abnormal proliferation of cells that resemble embryonic kidney cells (metanephroma), leading to the term embryonal tumor. It mainly affects young children between the ages of 1 and 5 years, although it can occur before the age of 1 year or after the age of 8 years. Adult forms are very rare. The tumor is usually present as an abdominal mass, which is frequently unilateral. Other symptoms may include abdominal pain, hypertension, fever, hematuria, and anemia. The disease progresses rapidly, with regional dissemination in the retroperitoneal space, lymph nodes, vessels (renal vein and inferior vena cava), and the peritoneal cavity in cases of tumor effraction, with a high likelihood of metastases in the lungs and liver. Nephroblastoma is sporadic in 99% of cases, with 10% of these cases associated with congenital anomalies or specific syndromes. Genetic anomalies have bee
Read more

Acromegaly – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
  Acromegaly is a disorder that occurs when your body makes too much growth hormone (GH). Produced mainly in the pituitary gland, GH controls the physical growth of the body. Acromegaly may also cause thickening of the body's soft tissues, including the heart, lips, and tongue. When the disease affects children prior to the end of puberty, excess growth hormone can lead to accelerated growth and tall stature, known as gigantism. Acromegaly affects between 3 and 14 people out of every 100,000. Thelansis’s “Acromegaly Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Acromegaly treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and Chin
Read more